Dyadic International, Inc.

Healthcare · Biotechnology · United States

Last price 0.3802 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 13.85M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research a...